What are the anti-inflammatory drugs for cervical erosion?

Cervical erosion is very common among gynecological diseases and also troubles many women. There are many reasons for female cervical erosion, among which unclean sexual life or artificial abortion are closely related. If cervical erosion is severe, it will affect women's fertility, so correct treatment measures must be taken in time. So, what are the anti-inflammatory drugs suitable for cervical erosion?

What are the anti-inflammatory drugs for cervical erosion

Generally, cervical ulcers can be treated with vaginal suppositories such as Erectile Dysfunction Jecarbomer Gel or Baofukang Suppositories, Xiaomi Suppositories, etc., and oral anti-cervical ulcer soft capsules. Pay attention to rest and hygiene, keep the vulva dry, avoid spicy and irritating foods, and have regular check-ups.

Clinical manifestations

Cervical columnar epithelium ectopia is a normal physiological phenomenon and has no special clinical manifestations. Some people may experience contact bleeding, but this is just an individual difference in the cervix, just like some people will bleed from their teeth or mouth when they chew something hard.

If the amount of vaginal discharge increases, becomes yellow, and has an odor, it is a sign of cervical inflammation. The cyst and hypertrophy of the cervix are also the result of chronic cervical inflammation.

treat

Cervical columnar epithelium ectopia does not require any treatment, and many current methods of treating cervical erosion are wrong. But for symptomatic cervicitis, treatment is needed. Acute inflammation is treated with suppositories, while chronic inflammation can be treated with physical therapy such as laser or freezing.

prevention

Regular examination of the cervix is ​​necessary, not to prevent cervical erosion, but to prevent cervical cancer. The occurrence of cervical cancer is related to infection with human papillomavirus (HPV). Some patients infected with high-risk HPV are prone to precancerous lesions and cervical cancer when they are persistently infected at the squamous-columnar junction of the cervix. Since the advent of cervical smear testing, the mortality rate of cervical cancer has dropped significantly. The key is early prevention and treatment. It is currently recommended that women over the age of 21 should undergo a cervical smear test once a year. After the age of 30, an HPV test can be combined. If three consecutive HPV and cervical smear tests are negative, the interval can be extended to once every three years. Screening can be stopped after the age of 65.